SHAREHOLDER ALERT: Weiss Law Reminds GPN, SHBI, CBIO, and AJRD Shareholders About Its Ongoing Investigations

SHAREHOLDER ALERT: Weiss Law Reminds GPN, SHBI, CBIO, and AJRD Shareholders About Its Ongoing Investigations

PR Newswire

NEW YORK, Feb. 16, 2023 /PRNewswire/ --

If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:

Joshua Rubin, Esq.
Weiss Law
305 Broadway, 7th Floor
New York, NY 10007
(212) 682-3025
(888) 593-4771
[email protected]

Global Payments Inc. (NYSE: GPN)

Weiss Law, a national shareholder rights law firm, is investigating possible breaches of fiduciary duty and violations of the federal securities laws by the Board of Directors and senior officers of Global Payments Inc. (NYSE: GPN) and its wholly owned subsidiary, Active Network, for engaging in deceptive business practices to enroll consumers in discount club memberships without customer knowledge or consent and for renewing said memberships in violation of Regulation E of the Electronic Fund Transfer Act. If you own GPN shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslaw.co/news-and-cases/gpn

Shore Bancshares, Inc. (NASDAQ: SHBI)

Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Shore Bancshares, Inc. (NASDAQ: SHBI), in connection with the proposed merger of SHBI with The Community Financial Corporation. If you own SHBI shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslaw.co/news-and-cases/shbi

Catalyst Biosciences, Inc. (NASDAQ: CBIO)

Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Catalyst Biosciences, Inc. (NASDAQ: CBIO), in connection with the proposed purchase of GNI Group Ltd.'s ("GNI") proprietary new chemical entity F351 ("F351"). This purchase will transfer the global rights to F351 (excluding Mainland China) to CBIO in consideration of 6,266,521 shares of common stock and 12,340 shares of a new series of preferred stock ("Series X") with economic rights equivalent to CBIO common stock to be paid for GNI's 65.18% interest of Beijing Continent, a China based commercial-stage pharmaceutical company marketing pirfenidone and having the rights to F351 in China. If you own CBIO shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslaw.co/news-and-cases/cbio

Aerojet Rocketdyne Holdings, Inc. (NYSE: AJRD)

Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Aerojet Rocketdyne Holdings, Inc. (NYSE: AJRD), in connection with the proposed acquisition of AJRD by L3Harris Technologies, Inc. Under the terms of the merger agreement, AJRD shareholders will receive $58.00 in cash for each share of AJRD common stock owned. If you own AJRD shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslaw.co/news-and-cases/ajrd

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-weiss-law-reminds-gpn-shbi-cbio-and-ajrd-shareholders-about-its-ongoing-investigations-301749341.html

SOURCE Weiss Law

Copyright CNW Group 2023